Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextroamphetamine + tDCS + MIT for Post-Stroke Aphasia
NCT02514044Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Mar 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dextroamphetamine in aphasia, sponsored by UTHealth Houston. Started Mar 2015; status: completed.
02
Drugs
dextroamphetamine
03
Conditions
aphasia
Beyond the preview
Go deeper on NCT02514044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02514044.